Inventor · disambiguated record
Donald P. Matthews
Also filed as: MATTHEWS DONALD P · MATTHEWS DONALD PAUL · RENZI ALFRED A · WAGNER EUGENE R
51 granted patents·4 pending applications·544 citations·filing 1976–2012
98Inventor score
Files withLILLY CO ELI18MERRELL DOW PHARMA16MERRELL PHARMA INC9DOW CHEMICAL CO7COGHLAN MICHAEL JOSEPH1
Top patents by PatentIndex Score
55 records- 0197US5120764AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1988·Granted Jun 9, 1992·167 cites·2 claims
- 0291US6417212B1Modulators of peroxisome proliferator activated receptorsLILLY CO ELI·Filed 2000·Granted Jul 9, 2002·37 cites·55 claims
- 0391US6265581B1Selective β3 adrenergic agonistsLILLY CO ELI·Filed 2000·Granted Jul 24, 2001·23 cites·2 claims
- 0488US7968587B2Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulatorsLILLY CO ELI·Filed 2007·Granted Jun 28, 2011·15 cites·20 claims
- 0588US4325959AHypoglycemic 4-(((1,3,4, thiadiazolyl)thio)methyl)benzoic acids, ester and amidesDOW CHEMICAL CO·Filed 1979·Granted Apr 20, 1982·15 cites·23 claims
- 0683US7935722B2Tetrahydrocarbazole derivatives useful as androgen receptor modulatorsLILLY CO ELI·Filed 2006·Granted May 3, 2011·7 cites·19 claims
- 0782US5977325A2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivativesMERRELL PHARMA INC·Filed 1998·Granted Nov 2, 1999·47 cites·13 claims
- 0882US5786356ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Jul 28, 1998·38 cites·20 claims
- 0981US6610696B2Modulators of peroxisome proliferator activated receptorsLILLY CO ELI·Filed 2002·Granted Aug 26, 2003·12 cites·42 claims
- 1077US5378693A2'-halomethylidene cytidine, uridine and guanosine compounds and their pharmaceutical compositionsMERRELL DOW PHARMA·Filed 1993·Granted Jan 3, 1995·27 cites·14 claims
- 1176US7411072B2Tricyclic steroid hormone nuclear receptor modulatorsLILLY CO ELI·Filed 2003·Granted Aug 12, 2008·8 cites·7 claims
- 1275US6825222B2Modulators of peroxisome proliferator activated receptorsLILLY CO ELI·Filed 2003·Granted Nov 30, 2004·6 cites·33 claims
- 1373US4328244ANovel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereofDOW CHEMICAL CO·Filed 1980·Granted May 4, 1982·11 cites·18 claims
- 1472US5525633ATriaryl-ethylene derivativesMERRELL DOW PHARMA·Filed 1994·Granted Jun 11, 1996·12 cites·15 claims
- 1570US7655641B2Sulfonamide derivatives as PPAR modulatorsLILLY CO ELI·Filed 2004·Granted Feb 2, 2010·5 cites·19 claims
- 1669US5840738ASelective β-3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Nov 24, 1998·10 cites·17 claims
- 1762US5684004ATriaryl-ethylene derivativesMERRELL PHARMA INC·Filed 1995·Granted Nov 4, 1997·9 cites·12 claims
- 1862US4218475AHypolipidemic benzylaminobenzene alkanoic or alkenoic acidsDOW CHEMICAL CO·Filed 1978·Granted Aug 19, 1980·4 cites·7 claims
- 1961US7803814B2Tricyclic steroid hormone nuclear receptor modulatorsLILLY CO ELI·Filed 2004·Granted Sep 28, 2010·1 cites·15 claims
- 2061US5607925ATreatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosidesMERRELL PHARMA INC·Filed 1994·Granted Mar 4, 1997·12 cites·6 claims
- 2161US4810800ANovel imidazole dopamine beta hydroxylase inhibitorsMERRELL DOW PHARMA·Filed 1988·Granted Mar 7, 1989·5 cites·9 claims
- 2259US7482344B2Tricyclic steroid hormone nuclear receptor modulatorsLILLY CO ELI·Filed 2004·Granted Jan 27, 2009·1 cites·13 claims
- 2358US5616702A2-'-ethenylidene cytidine, uridine and guanosine derivativesMERRELL PHARMA INC·Filed 1994·Granted Apr 1, 1997·7 cites·13 claims
- 2458US2004063659A1Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivativesMERRELL PHARMA INC·Filed 2003·Application pending·0 cites
- 2557US5760210AProcess for the preparation of ribonucleotide reductase inhibitorsMERRELL PHARMA INC·Filed 1996·Granted Jun 2, 1998·5 cites·1 claims
- 2657US5512678A5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agentsMERRELL PHARMA INC·Filed 1994·Granted Apr 30, 1996·9 cites·8 claims
- 2757US5508393AProcess for the preparation of ribonucleotide reductase inhibitorsHOESCHST MARION ROUSSEL INC·Filed 1995·Granted Apr 16, 1996·7 cites·3 claims
- 2856US2009149445A1Tricyclic steroid hormone nuclear receptor modulatorsCOGHLAN MICHAEL JOSEPH·Filed 2008·Application pending·0 cites
- 2954US5589587AProcess for the preparation of ribonucleotide reductase inhibitorsMERRELL PHARMA INC·Filed 1995·Granted Dec 31, 1996·8 cites·3 claims
- 3054US2003109484A1Novel 2'-halomethylidene, 2'-ethenylidene and 2'ethynyl cytidine, uridine and guanosine derivativesFiled 2002·Application pending·0 cites
- 3153US2008167310A1Modulators of peroxisome proliferator activated receptors (ppar)GOSSETT LYNN STACY·Filed 2007·Application pending·0 cites
- 3249US8658693B24-aminobenzonitrile selective androgen receptor modulatorsLILLY CO ELI·Filed 2012·Granted Feb 25, 2014·0 cites·23 claims
- 3349US5147863A2,2'-bi-1H-imidazolesMERRELL DOW PHARMA·Filed 1990·Granted Sep 15, 1992·3 cites·14 claims
- 3449US4409227A4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical useDOW CHEMICAL CO·Filed 1982·Granted Oct 11, 1983·2 cites·42 claims
- 3548US5189052AThione dopamine beta hydroxylase inhibitorsMERRELL DOW PHARMA·Filed 1989·Granted Feb 23, 1993·2 cites·8 claims
- 3647US7282501B2Modulators of peroxisome proliferator activated receptors (PPAR)LILLY CO ELI·Filed 2002·Granted Oct 16, 2007·0 cites·18 claims
- 3747US6075040ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Jun 13, 2000·2 cites·16 claims
- 3846US6093735ASelective β-3 adrenergic agonistsLILLY CO ELI·Filed 1999·Granted Jul 25, 2000·4 cites·17 claims
- 3946US5112852AAllenyl aminesMERRELL DOW PHARMA·Filed 1989·Granted May 12, 1992·2 cites·11 claims
- 4046US4847288AAllenyl aminesMERRELL DOW PHARMA·Filed 1988·Granted Jul 11, 1989·2 cites·11 claims
- 4146US4105791AHypolipidemic cycloalkylaminobenzoic acidsDOW CHEMICAL CO·Filed 1976·Granted Aug 8, 1978·2 cites·30 claims
- 4245US5017591AThiazolyl methyl)-2-2'-Bi-1H-imidazoles and use as hypertensive agentsMERRELL DOW PHARMA·Filed 1990·Granted May 21, 1991·2 cites·7 claims
- 4343US4788335AHypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium saltsMERRELL DOW PHARMA·Filed 1987·Granted Nov 29, 1988·4 cites·4 claims
- 4443US4192884ASubstituted 4-(((thienyl)methyl)-amino)benzoic acids and a method for treating hypolipidemiaDOW CHEMICAL CO·Filed 1978·Granted Mar 11, 1980·1 cites·27 claims
- 4542US5792841A2'-halomethylidene, 2'-ethenylidene and 2'-ethynl cytidine, uridine and guanosine derivativesMERRELL PHARMA INC·Filed 1996·Granted Aug 11, 1998·2 cites·13 claims
- 4642US5057613ANovel thione dopamine beta hydroxylase inhibitorsMERRELL DOW PHARMA·Filed 1987·Granted Oct 15, 1991·1 cites·3 claims
- 4740US4929744AProcess for preparing heteroaromatic methyl)-2,2'-bi-1H-imidazolesMERRELL DOW PHARMA·Filed 1989·Granted May 29, 1990·1 cites·2 claims
- 4837US6060492ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted May 9, 2000·1 cites·22 claims
- 4935US4857663AHypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium saltsMERRELL DOW PHARMA·Filed 1988·Granted Aug 15, 1989·3 cites·2 claims
- 5033US4981868APharmaceutically active 3-heteroaryl-2-fluoro-1-olefinsMERRELL DOW PHARMACEUTICAL·Filed 1989·Granted Jan 1, 1991·1 cites·6 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Donald P. Matthews files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →